Illexcor Therapeutics
Illexcor Therapeutics is a biopharmaceutical company developing next-generation oral therapies for sickle cell disease (SCD). Their lead asset is a first-in-class oral drug designed to target the root cause of SCD, offering the potential for disease-modifying clinical benefits.
Funding Round: Strategic Investment
Funding Amount:
Date: 12-Mar-2025
Investors: Zynext Ventures USA LLC
Markets: Biotech, Pharmaceuticals, Therapeutics
HQ: Richmond, Virginia, United States
Founded: 2020
Website: https://www.illexcor.com/
LinkedIn: https://www.linkedin.com/company/illexcor-therapeutics-llc
Crunchbase: https://www.crunchbase.com/organization/illexcor-therapeutics
Leave a Comment
Comments
No comments yet.